213 related articles for article (PubMed ID: 8556059)
21. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
Romei C; Elisei R; Pinchera A; Ceccherini I; Molinaro E; Mancusi F; Martino E; Romeo G; Pacini F
J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377
[TBL] [Abstract][Full Text] [Related]
22. A novel deletion in the RET proto-oncogene found in sporadic medullary thyroid carcinoma.
Alemi M; Lucas SD; Sällström JF; Akerström G; Wilander E
Anticancer Res; 1996; 16(5A):2619-22. PubMed ID: 8917360
[TBL] [Abstract][Full Text] [Related]
23. Absence of mutations at codon 768 of the RET proto-oncogene in sporadic and hereditary pheochromocytomas.
Yoshimoto K; Kimura T; Tanaka C; Moritani M; Iwahana H; Itakura M
Endocr J; 1996 Feb; 43(1):109-14. PubMed ID: 8732460
[TBL] [Abstract][Full Text] [Related]
24. Novel point mutations and allele loss at the RET locus in sporadic medullary thyroid carcinomas.
Uchino S; Noguchi S; Adachi M; Sato M; Yamashita H; Watanabe S; Murakami T; Toda M; Murakami N; Yamashita H
Jpn J Cancer Res; 1998 Apr; 89(4):411-8. PubMed ID: 9617347
[TBL] [Abstract][Full Text] [Related]
25. Tumor-specific mutations in the tyrosine kinase domain of the RET proto-oncogene in pheochromocytomas of sporadic type.
Yoshimoto K; Tanaka C; Hamaguchi S; Kimura T; Iwahana H; Miyauchi A; Itakura M
Endocr J; 1995 Apr; 42(2):265-70. PubMed ID: 7627271
[TBL] [Abstract][Full Text] [Related]
26. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.
Eng C; Smith DP; Mulligan LM; Healey CS; Zvelebil MJ; Stonehouse TJ; Ponder MA; Jackson CE; Waterfield MD; Ponder BA
Oncogene; 1995 Feb; 10(3):509-13. PubMed ID: 7845675
[TBL] [Abstract][Full Text] [Related]
27. Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma.
Eng C; Mulligan LM; Smith DP; Healey CS; Frilling A; Raue F; Neumann HP; Pfragner R; Behmel A; Lorenzo MJ
Genes Chromosomes Cancer; 1995 Mar; 12(3):209-12. PubMed ID: 7536460
[TBL] [Abstract][Full Text] [Related]
28. Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma.
Chiefari E; Russo D; Giuffrida D; Zampa GA; Meringolo D; Arturi F; Chiodini I; Bianchi D; Attard M; Trischitta V; Bruno R; Giannasio P; Pontecorvi A; Filetti S
J Endocrinol Invest; 1998 Jun; 21(6):358-64. PubMed ID: 9699127
[TBL] [Abstract][Full Text] [Related]
29. Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene.
Akama H; Noshiro T; Kimura N; Shimizu K; Watanabe T; Shibukawa S; Nakai S; Miura W; Ito S; Miura Y
Intern Med; 1999 Feb; 38(2):145-9. PubMed ID: 10225670
[TBL] [Abstract][Full Text] [Related]
30. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
Hofstra RM; Landsvater RM; Ceccherini I; Stulp RP; Stelwagen T; Luo Y; Pasini B; Höppener JW; van Amstel HK; Romeo G
Nature; 1994 Jan; 367(6461):375-6. PubMed ID: 7906866
[TBL] [Abstract][Full Text] [Related]
31. "Cold" single-strand conformational variants for mutation analysis of the RET protooncogene.
Musholt PB; Musholt TJ; Goodfellow PJ; Zehnbauer BA; Wells SA; Moley JF
Surgery; 1997 Aug; 122(2):363-70; discussion 370-1. PubMed ID: 9288142
[TBL] [Abstract][Full Text] [Related]
32. The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects.
Beldjord C; Desclaux-Arramond F; Raffin-Sanson M; Corvol JC; De Keyzer Y; Luton JP; Plouin PF; Bertagna X
J Clin Endocrinol Metab; 1995 Jul; 80(7):2063-8. PubMed ID: 7608256
[TBL] [Abstract][Full Text] [Related]
33. RET proto-oncogene point mutations in sporadic neuroendocrine tumors.
Komminoth P; Roth J; Muletta-Feurer S; Saremaslani P; Seelentag WK; Heitz PU
J Clin Endocrinol Metab; 1996 Jun; 81(6):2041-6. PubMed ID: 8964826
[TBL] [Abstract][Full Text] [Related]
34. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.
Bugalho MJ; Domingues R; Santos JR; Catarino AL; Sobrinho L
Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172
[TBL] [Abstract][Full Text] [Related]
35. Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas.
Zedenius J; Larsson C; Bergholm U; Bovée J; Svensson A; Hallengren B; Grimelius L; Bäckdahl M; Weber G; Wallin G
J Clin Endocrinol Metab; 1995 Oct; 80(10):3088-90. PubMed ID: 7559902
[TBL] [Abstract][Full Text] [Related]
36. A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A.
Berndt I; Reuter M; Saller B; Frank-Raue K; Groth P; Grussendorf M; Raue F; Ritter MM; Höppner W
J Clin Endocrinol Metab; 1998 Mar; 83(3):770-4. PubMed ID: 9506724
[TBL] [Abstract][Full Text] [Related]
37. Large-scale analysis of mutations in RET exon 16 in sporadic medullary thyroid carcinomas in Japan.
Takano T; Miyauchi A; Yoshida H; Hasegawa Y; Kuma K; Amino N
Jpn J Cancer Res; 2001 Jun; 92(6):645-8. PubMed ID: 11429053
[TBL] [Abstract][Full Text] [Related]
38. Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC.
Kitamura Y; Goodfellow PJ; Shimizu K; Nagahama M; Ito K; Kitagawa W; Akasu H; Takami H; Tanaka S; Wells SA
Oncogene; 1997 Jun; 14(25):3103-6. PubMed ID: 9223675
[TBL] [Abstract][Full Text] [Related]
39. 27-bp deletion in the ret proto-oncogene as a somatic mutation associated with medullary thyroid carcinoma.
Kalinin V; Frilling A
J Mol Med (Berl); 1998 Apr; 76(5):365-7. PubMed ID: 9587071
[TBL] [Abstract][Full Text] [Related]
40. Exon 5 of the RET proto-oncogene: a newly detected risk exon for familial medullary thyroid carcinoma, a novel germ-line mutation Gly321Arg.
Dvorakova S; Vaclavikova E; Duskova J; Vlcek P; Ryska A; Bendlova B
J Endocrinol Invest; 2005 Nov; 28(10):905-9. PubMed ID: 16419493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
